Akshay Vaishnaw, M.D., Ph.D.

Dr. Akshay Vaishnaw has served as President of R&D of Scholar Rock since April 2025, and has served as a member of Scholar Rock's board of directors since May 2019. He is a venture partner with over 25 years of experience in the biotechnology industry. Since 2006, he served in positions of increasing responsibility across Research and Development (R&D) at Alnylam Pharmaceuticals, and most recently served as President of Alnylam Pharmaceuticals. Previously, Akshay held various positions in clinical research and business development at Biogen.

He is a board member Hemab and the non-profit, TB Alliance. Previously, he served on the Boards of Visterra, Inc, and Editas Medicine Inc.

Akshay received a bachelor’s degree from University College Cardiff, UK, an MD from the University of Wales College of Medicine, UK, and a PhD from the University of London, UK, in Molecular Immunology. He is a Fellow of the Royal College of Physicians, UK.